The upgrade in the price target by a reputable analyst like Ashwani Verma from UBS is a strong positive signal for Legend Biotech. It suggests a bullish outlook on the stock's future performance, likely due to anticipated operational successes or financial improvements. This can lead to increased investor confidence and potentially drive the stock price up in the short term.